Prevalence, Clinical Features, and Outcomes of Young Patients with Idiopathic Pulmonary Fibrosis
While younger IPF patients had a lower risk of mortality and lung transplantation, with no significant differences in the risk of AEs, they were less likely to receive antifibrotic therapy and more often treated with steroids, which may affect outcomes. Early, targeted treatment strategies, including antifibrotic use, are crucial for improving their prognosis.
Authors
- Jung Hyun Nam (ORCID: https://orcid.org/0000-0002-1871-4269)
- Joon Young Choi (ORCID: https://orcid.org/0000-0001-6298-2204)
- Chin Kook Rhee (ORCID: https://orcid.org/0000-0003-4533-7937)
- Yong Suk Jo (ORCID: https://orcid.org/0000-0002-6422-6530)
- Kyung Joo Kim
- Jeewon Lee (ORCID: https://orcid.org/0000-0001-7712-3373)
Institutions
- The Catholic University of Korea Incheon St. Mary's Hospital (KR)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- Respiration
- Published
- 2024-11-07
- DOI
- https://doi.org/10.1159/000541692
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00